The Trump administration suspects that physicians may be regularly performing medically unnecessary peripheral vascular procedures in office-based labs, according to a recent investigation released by the Office of Inspector General and HHS in May.
In 2008 CMS put policies in place to incentivize performing peripheral vascular procedures in office-based labs in order to save costs. But according to the report, physicians may now be going out of their way to perform peripheral vascular procedures that are not medically necessary in office-based labs.
Here are five takeaways from the OIG report and what they mean for cardiologists:
1. Medicare paid physicians approximately $548 million for performing peripheral vascular procedures in office-based labs in 2023.
2. The OIG estimates approximately 19%, or $105 million, of these procedures may have been medically unnecessary.
3. These potentially fraudulent payments were received by a total of 139 physicians, or 7% of the total physicians included in the government’s analysis across vascular surgery, cardiology, interventional cardiology and interventional radiology.
4. “Although determining whether these physicians engaged in abusive or fraudulent practices was not within the scope of this study, their billing patterns warrant further scrutiny,” the government wrote in the report. The report identified questionable procedures using four different measures:
- Physicians billing a tibial procedure for at least 95%of Medicare patients
- Physicians billing an above-average number of peripheral vascular procedures per Medicare patient
- Physicians regularly billing for more complex peripheral vascular procedures per surgical session
- Physicians billing a high percentage of patients with early-stage PAD.
5. The OIG recommended that CMS monitor the billing of these procedures going forward and follow up with any physicians linked to suspicious billing patterns.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
